Protein detail
ENOB
Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase)
Entry name ENOB | UniProt ID | EVMP confidence score 0.53 |
Supporting publications (n) 2 | Transmembrane count | Protein classification Candidate cardiovascular disease genesDisease related genesEnzymesHuman disease related genesMetabolic proteinsPlasma proteinsPotential drug targetsPredicted intracellular proteins |
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30Basic Information
Protein Names
Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase)
Protein Class (8)
Candidate cardiovascular disease genesDisease related genesEnzymesHuman disease related genesMetabolic proteinsPlasma proteinsPotential drug targetsPredicted intracellular proteins
Protein Function (7)
- Human disease related genes:Congenital disorders of metabolism:Congenital disorders of carbohydrate metabolism
- Predicted intracellular proteins
- ENZYME proteins:Lyases
- Potential drug targets
- Candidate cardiovascular disease genes
- Enzymes
- Disease related genes
Ensembl
Entrez Gene Symbol
Gene Description
Enolase 3
Chromosome
17
Position
4948092-4957131
Supporting publications (n)
2
EVMP confidence score
0.53
Fluorescence & Localization
Tissue Specificheart muscleCell SpecificCardiomyocytes
Function & Pathway
Protein Function (7)
- Human disease related genes:Congenital disorders of metabolism:Congenital disorders of carbohydrate metabolism
- Predicted intracellular proteins
- ENZYME proteins:Lyases
- Potential drug targets
- Candidate cardiovascular disease genes
- Enzymes
- Disease related genes
Cellular Component (6)
Molecular Function (3)
Biological Process (3)
KEGG (7)
Reactome (3)
Mediation Categories
Metabolism mediation
Relations & Evidence20
Ligand-Receptor Signaling (9)
9 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| ecm | ecm | MatrixDB | Yes | ||||
| ecm | ecm | OmniPath | Yes | ||||
| extracellular | extracellular | LOCATE | |||||
| extracellular | extracellular | OmniPath | |||||
| intracellular | intracellular | LOCATE | |||||
| intracellular | intracellular | ComPPI | |||||
| intracellular | intracellular | GO_Intercell | |||||
| intracellular | intracellular | UniProt_location | |||||
| intracellular | intracellular | OmniPath |
Protein Complex Composition (10)
10 records.
| Component Name | Component Gene Symbols | Component UniProt ID | Stoichiometry | Database | Database IDs | References |
|---|---|---|---|---|---|---|
| ENO3GPIPGK1PGK2 | P00558P06744P07205P13929 | 0:0:0:0 | hu.MAP | |||
| ENO3PGK1PGK2TSFM | P00558P07205P13929P43897 | 0:0:0:0 | hu.MAP | |||
| ENO3GFUSPGK1PGK2TSFM | P00558P07205P13929P43897Q13630 | 0:0:0:0:0 | hu.MAP | |||
| ENO3GPIGSTO1MPIPARK7PGK2PGM2TKT | P06744P07205P13929P29401P34949P78417Q96G03Q99497 | 0:0:0:0:0:0:0:0 | hu.MAP | |||
| ENO3GPIPDCD6IPPEF1TMEM256 | P06744P13929Q8N2U0Q8WUM4Q9UBV8 | 0:0:0:0:0 | Havugimana2012 | Havugimana2012:C_426 | ||
| ENO3IDH2MTHFD1 | P11586P13929P48735 | 0:0:0 | hu.MAP2 | |||
| ENO3 | P13929 | 2 | PDB | PDB:2xsx | ||
| CALRENO3RCN3 | P13929P27797Q96D15 | 0:0:0 | hu.MAP | |||
| CALRENO3WRAP53 | P13929P27797Q9BUR4 | 0:0:0 | hu.MAP | |||
| AKR1D1ENO3GSTO1 | P13929P51857P78417 | 0:0:0 | hu.MAP2 |
Isolation & Detection Technology (1)
1 record.
| EV Isolation Method | Detection Method | Number of References | References |
|---|---|---|---|
| Differential Ultracentrifugation | Small R sequencing (Illumi HiSeq 2000 (Solexa)Mass spectrometry | 1 | 37886648 |
Sequence, Structure & Domains
Sequences
Length
434
Mass
46,987
Sequence
MAMQKIFAREILDSRGNPTVEVDLHTAKGRFRAAVPSGASTGIYEALELRDGDKGRYLGKGVLKAVENINNTLGPALLQKKLSVVDQEKVDKFMIELDGTENKSKFGANAILGVSLAVCKAGAAEKGVPLYRHIADLAGNPDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGASSFKEAMRIGAEVYHHLKGVIKAKYGKDATNVGDEGGFAPNILENNEALELLKTAIQAAGYPDKVVIGMDVAASEFYRNGKYDLDFKSPDDPARHITGEKLGELYKSFIKNYPVVSIEDPFDQDDWATWTSFLSGVNIQIVGDDLTVTNPKRIAQAVEKKACNCLLLKVNQIGSVTESIQACKLAQSNGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEALGDKAIFAGRKFRNPKAK
Alternative Products
Event=Alternative splicing; Named isoforms=3; Name=1; IsoId=P13929-1; Sequence=Displayed; Name=2; IsoId=P13929-2; Sequence=VSP_037753; Name=3; IsoId=P13929-3; Sequence=VSP_037752
Alternative Sequence
61..104; GVLKAVENINNTLGPALLQKKLSVVDQEKVDKFMIELDGTENKS -> A (in isoform 3); 150..177; Missing (in isoform 2)
3D Structural Models
Turn
104..106; 237..239; 259..262; 319..323
Helix
57..59; 63..71; 73..79; 87..98; 108..125; 130..138; 156..158; 178..200; 220..234; 248..251; 267..269; 273..286; 301..309; 325..334; 344..347; 350..362; 380..388; 401..417; 418..420; 425..427
Beta Strand
5..12; 18..26; 29..34; 43..45; 150..154; 159..162; 167..171; 241..245; 289..293; 313..318; 338..342; 366..370; 391..394
3D Structure
X-ray crystallography (1)
Domain & Motif Annotations
Protein Families
Enolase family
Sequence Similarities
Belongs to the enolase family.
Clinical Relevance
Disease Involvement (2)
Disease variantGlycogen storage disease
Related Diseases
Drugs (2)
Interaction Protein
ENSG00000074800
Interaction Count
1
Interaction Dataset
intact_biogrid_opencell
Supporting Publications2
| PMID | Title | Related sentences |
|---|---|---|
| 37503071 | A novel machine learning algorithm selects proteome signature to specifically identify cancer exosomes. | Employing datasets of exosome proteins from human cell lines, tissue, plasma, serum and urine samples from a variety of cancers, we identify Clathrin Heavy Chain (CLTC), Ezrin, (EZR), Talin-1 (TLN1), Adenylyl cyclase-associated protein 1 (CAP1) and Moesin (MSN) as highly abundant universal biomarkers for exosomes and define three panels of pan-cancer exosome proteins that distinguish cancer exosomes from other exosomes and aid in classifying cancer subtypes employing random forest models. |
| 38529947 | A novel machine learning algorithm selects proteome signature to specifically identify cancer exosomes. | Employing datasets of exosome proteins from human cell lines, tissue, plasma, serum, and urine samples from a variety of cancers, we identify Clathrin Heavy Chain (CLTC), Ezrin, (EZR), Talin-1 (TLN1), Adenylyl cyclase-associated protein 1 (CAP1), and Moesin (MSN) as highly abundant universal biomarkers for exosomes and define three panels of pan-cancer exosome proteins that distinguish cancer exosomes from other exosomes and aid in classifying cancer subtypes employing random forest models. |